Texas Woman's University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Texas Woman's University sits in the top decile of US sponsors by registered trial count (#372 of 15,742 sponsors by registered trial count).
Texas Woman's University: 51 sponsored US clinical trials, 3 recruiting.
Texas Woman's University sponsors 51 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 39 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Dry Needling, with 3 trials.
Top-decile sponsor footprint
Texas Woman's University ranks in the top decile of sponsors by registered trial count (#372 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
39 of 42 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Therapeutic Areas
What is open in the Texas Woman's University pipeline
3 recruiting of 51 indexed (6% open); 39 completed (76%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Dry Needling (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Texas Woman's University: open-pipeline peers nationwide
Peers matched on 51 registered trials and 6% open enrollment, not the therapeutic-area sidebar.
Texas Woman's University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 51 trials (± recruiting share)
- Colgate Palmolive · 51 trials · 6% recruiting
- MedtronicNeuro · 51 trials · 4% recruiting
- Ohio University · 51 trials · 10% recruiting
- Reproductive Medicine Associates of New Jersey · 51 trials · 14% recruiting
Sponsors near 6% open enrollment (± trial volume)
- BioDelivery Sciences International · 6% recruiting · 17 trials
- Durham VA Medical Center · 6% recruiting · 17 trials
- Essentia Health · 6% recruiting · 17 trials
- Madrigal Pharmaceuticals · 6% recruiting · 17 trials
Related
What to do with this Texas Woman's University page
51 registered trials is a research-attention snapshot, not an endorsement of Texas Woman's University or any single study.
- 3 of Texas Woman's University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Dry Needling is the condition Texas Woman's University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Dry Needling trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Texas Woman's University pipeline card: 51 registered trials from official public datasets.Report a data error.